NASDAQ: MCTACharming Medical Ltd Stock
$7.00
Updated Oct 21, 2025
MCTA Price
$7.00
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$4.30
52 Week High
$8.21
P/E
87.5x
P/B
N/A
P/S
N/A
PEG
2x
Dividend Yield
N/A
Revenue
$6.22M
Earnings
$1.20M
Gross Margin
70.2%
Operating Margin
23.4%
Profit Margin
19.3%
Debt to Equity
107.76
Operating Cash Flow
$426k
Beta
N/A
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
MCTA Overview
Charming Medical Limited, through its subsidiaries, engage in the provision of beauty, wellness, and postpartum services under the Beauty Lab brand name in Hong Kong. Its services includes womb-warming therapy, BTS (Beauty, Tailor-made, Slim) pelvic detox therapy, agarwood moxibustion therapy, traditional Chinese medicine (TCM)-inspired prenatal massage, and Indonesian traditional abdominal binding. The company also provides TCM-inspired supplements products, which includes Beauty Lab home herbal uterine care patch, probiotic intimate wash, and Yin nourishing pill sets; and beauty products, including ginseng soothing anti-allergy moisturizing wash for skin issues, and scalp health. In addition, it offers consultancy services to provide TCM-inspired therapy technical training and dietary therapy training to other well-established and reputable beauty salons, massage centers, and similar institutions. Further, the company's products are used for the treatment of alleviating premenstrual syndrome, menstrual irregularities, dysmenorrhea, leukorrhea, pelvic inflammatory disease, menopausal care, breast health, uterine health, enhance physical weakness, balance endocrine functions, and other common women's health issues. it operates wellness centres. The company was founded in 2016 and is headquartered in Causeway Bay, Hong Kong.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MCTA's potential to beat the market
- MCTA doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
A
MCTA
RankedUnranked of 41
RankedUnranked of 41
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.23 | A | |
| $16.90 | A | |
| $14.97 | A |
Be the first to know about important MCTA news, forecast changes, insider trades & much more!
MCTA News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MCTA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MCTA ($7.00) is trading above its intrinsic value of $1.83, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MCTA is poor value based on its earnings relative to its share price (87.5x), compared to the US market average (38.14x)
P/E vs Market Valuation
MCTA is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more MCTA due diligence checks available for Premium users.
Valuation
MCTA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
87.5x
Industry
17.32x
Market
38.14x
MCTA is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MCTA is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
MCTA price to earnings growth (PEG)
For valuing profitable companies with growth potential
MCTA is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
MCTA's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
MCTA's Earnings (EBIT) of $1.46M... subscribe to Premium to read more.
Interest Coverage Financials
MCTA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.4M
Liabilities
$5.3M
Debt to equity
107.76
MCTA's short-term liabilities ($4.95M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MCTA's short-term assets ($3.37M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MCTA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
MCTA's operating cash flow ($425.89k)... subscribe to Premium to read more.
Debt Coverage Financials
Charming Medical Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.